References
- Mishra NN, Prasad T, Sharma N, et al. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung 2007;54:201–35
- Lai CC, Tan CK, Huang YT, et al. Current challenges in the management of invasive fungal infections. J Infect Chemother 2008;14:77–85
- Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005;5:481–93
- Van Minnebruggen G, François IEJA, Cammue BPA, et al. A general overview on past, present and future antimycotics. Open Mycol J 2010;4:22–32
- Girmenia C. New generation azole antifungals in clinical investigation. Expert Opin Investig Drugs 2009;18:1279–95
- Guardiola HM, Foster L, Mushrush D, Vaz AD. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. Biochem Pharmacol 2001;61:1463–70
- Yoshida Y, Aoyama Y. Interaction of azole fungicides with yeast cytochrome P-450 which catalyzes lanosterol 14α-demethylation. In: Iwata K, Vanden Bossche H, eds. In vitro and in vivo evaluation of antifungal agents. Amsterdam: Elsevier Science; 1986:123–34
- Aoyama Y, Yoshida Y. The 3-hydroxy group of lanosterol is essential for orienting the substrate site of cytochrome P-450(14DM) (lanosterol 14 alpha-demethylase). Biochim Biophys Acta 1989;1006:209–13
- Ji H, Zhang W, Zhang M, et al. Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi. J Med Chem 2003;46:474–85
- Emami S, Falahati M, Banifatemi A, et al. Stereoselective synthesis and in vitro antifungal evaluation of (E)- and (Z)-imidazolylchromanone oxime ethers. Arch Pharm (Weinheim) 2002;335:318–24
- Emami S, Foroumadi A, Falahati M, et al. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents. Bioorg Med Chem Lett 2008;18:141–6
- Emami S, Falahati M, Banifatemi A, Shafiee A. Stereoselective synthesis and antifungal activity of (Z)-trans-3-azolyl-2-methylchromanone oxime ethers. Bioorg Med Chem 2004;12:5881–9
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A2; 2006; Wayne, Pennsylvania, USA
- Reulecke I, Lange G, Albrecht J, et al. Towards an integrated description of hydrogen bonding and dehydration: decreasing false positives in virtual screening with the HYDE scoring function. ChemMedChem 2008;3:885–97
- Schneider N, Hindle S, Lange G, et al. Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function. J Comput Aided Mol Des 2012;26:701–23
- Emami S, Shafiee A. Stereoselective syntheses of (E)- and (Z)-2,3-dihydro-3-(1,2,4-triazolyl)-4H-1-benzopyran-4-one oxime ethers. Heterocycles 2001;55:2059–74
- Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol 1996;261:470–89